AstraZeneca PLC
LSE:AZN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
AstraZeneca PLC
LSE:AZN
|
UK |
|
C
|
CD Projekt SA
SWB:7CD
|
PL |
|
H
|
Hiscox Ltd
F:H2X3
|
BM |
|
CMOC Group Ltd
SSE:603993
|
CN |
|
Xtract One Technologies Inc.
OTC:XTRAF
|
CA |
|
N
|
Novozymes A/S
DUS:NZM2
|
DK |
Wall St Price Targets
AZN Price Targets Summary
AstraZeneca PLC
According to Wall Street analysts, the average 1-year price target for AZN is 16 725.04 GBX with a low forecast of 11 413 GBX and a high forecast of 19 530 GBX.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AZN's stock price target?
Price Target
16 725.04
GBX
According to Wall Street analysts, the average 1-year price target for AZN is 16 725.04 GBX with a low forecast of 11 413 GBX and a high forecast of 19 530 GBX.
What is the Revenue forecast for AstraZeneca PLC?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 8 years is 5%.
What is the Gross Profit forecast for AstraZeneca PLC?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 8 years is 5%.
What is the Operating Income forecast for AstraZeneca PLC?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 8 years is 11%.
What is the Pre-Tax Income forecast for AstraZeneca PLC?
Projected CAGR
26%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 3 years is 26%.
What is the Net Income forecast for AstraZeneca PLC?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 8 years is 12%.
